Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 70.87% is in line with its 5-year average of 69.13%, near the high end of its 5-year range (65.43%–72.73%).
0.39% below its 12-month average of 71.15%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 72.73%.
GROSS MARGIN
70.87%
GROSS MARGIN AVG TTM
71.15%
GROSS MARGIN AVG 3Y
70.14%
GROSS MARGIN AVG 5Y
69.13%
GROSS MARGIN AVG 10Y
67.43%
GROSS MARGIN AVG 15Y
66.14%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.39%
CURRENT VS 3Y AVG
+1.04%
CURRENT VS 5Y AVG
+2.52%
CURRENT VS 10Y AVG
+5.11%
CURRENT VS 15Y AVG
+7.16%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+20.13%
vs the sector median at left
Market Cap
$29.44B
Gross Margin
42.90%
TTM Avg
40.85%
3Y Avg
40.34%
5Y Avg
40.27%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zoetis Inc. (ZTS) | $30.74B | 70.87% | 71.15% | 70.14% | 69.13% |
| Biogen Inc. (BIIB)vs › | $31.14B | 67.71% | 73.30% | 74.61% | 77.63% |
| Waters Corporation (WAT)vs › | $30.28B | 50.78% | 58.60% | 58.69% | 58.45% |
| DexCom, Inc. (DXCM)vs › | $31.65B | 62.47% | 60.28% | 62.12% | 63.92% |
| Centene Corp. (CNC)vs › | $31.66B | 16.13% | 11.28% | 11.33% | 11.71% |
| ResMed Inc. (RMD)vs › | $31.91B | 61.16% | 60.26% | 58.24% | 57.85% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.44B | 42.90% | 40.85% | 40.34% | 40.27% |
| Medline Inc. (MDLN)vs › | $28.79B | 25.02% | 25.55% | 23.71% | 23.71% |
| Alcon Inc. (ALC)vs › | $33.37B | 56.45% | 55.42% | 55.20% | 53.33% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.52B | 79.72% | 83.69% | 83.53% | 83.62% |
Gross Margin
70.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 72.73% |
| 2026-03-31 | 71.66% |
| 2025-12-31 | 68.87% |
| 2025-09-30 | 70.21% |
| 2025-06-30 | 72.28% |
| 2025-03-31 | 70.54% |
| 2024-12-31 | 68.02% |
| 2024-09-30 | 69.18% |
| 2024-06-30 | 70.22% |
| 2024-03-31 | 68.95% |
| 2023-12-31 | 65.43% |
| 2023-09-30 | 68.57% |
| 2023-06-30 | 70.46% |
| 2023-03-31 | 68.75% |
| 2022-12-31 | 66.27% |
| 2022-09-30 | 67.83% |
| 2022-06-30 | 67.74% |
| 2022-03-31 | 69.28% |
| 2021-12-31 | 67.46% |
| 2021-09-30 | 68.54% |
| 2021-06-30 | 68.74% |
| 2021-03-31 | 68.52% |
| 2020-12-31 | 64.53% |
| 2020-09-30 | 67.19% |
| 2020-06-30 | 68.28% |
| 2020-03-31 | 67.47% |
| 2019-12-31 | 65.95% |
| 2019-09-30 | 67.36% |
| 2019-06-30 | 67.42% |
| 2019-03-31 | 61.79% |
| 2018-12-31 | 62.72% |
| 2018-09-30 | 65.88% |
| 2018-06-30 | 66.78% |
| 2018-03-31 | 65.59% |
| 2017-12-31 | 67.12% |
| 2017-10-01 | 66.00% |
| 2017-07-02 | 63.59% |
| 2017-04-02 | 62.31% |
| 2016-12-31 | 61.86% |
| 2016-10-02 | 65.43% |
| 2016-07-03 | 66.97% |
| 2016-04-03 | 66.52% |
| 2015-12-31 | 61.07% |
| 2015-09-27 | 65.32% |
| 2015-06-28 | 63.66% |
| 2015-03-29 | 64.25% |
| 2014-12-31 | 62.80% |
| 2014-09-28 | 64.13% |
| 2014-06-29 | 64.34% |
| 2014-03-30 | 65.45% |
| 2013-12-31 | 62.84% |
| 2013-09-29 | 65.10% |
| 2013-06-30 | 62.66% |
| 2013-03-31 | 63.12% |
| 2012-12-31 | 63.18% |
| 2012-09-30 | 64.77% |
| 2012-06-30 | 65.45% |
| 2012-03-31 | 62.46% |
| 2011-12-31 | 62.82% |
| 2011-09-30 | 62.06% |
| 2011-06-30 | 57.73% |
| 2011-03-31 | 61.24% |
